These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23315399)

  • 21. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI.
    Thorsson L; Edsbäcker S; Conradson TB
    Eur Respir J; 1994 Oct; 7(10):1839-44. PubMed ID: 7828694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-proportional pharmacokinetics of budesonide inhaled via Turbuhaler.
    Kaiser H; Aaronson D; Dockhorn R; Edsbäcker S; Korenblat P; Källén A
    Br J Clin Pharmacol; 1999 Sep; 48(3):309-16. PubMed ID: 10510140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of two budesonide dry powder inhalers in the treatment of asthma in children.
    Vanto T; Hämäläinen KM; Vahteristo M; Wille S; Njå F; Hyldebrandt N;
    J Aerosol Med; 2004; 17(1):15-24. PubMed ID: 15120009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scintigraphic comparison of budesonide deposition from two dry powder inhalers.
    Newman SP; Pitcairn GR; Hirst PH; Bacon RE; O'Keefe E; Reiners M; Hermann R
    Eur Respir J; 2000 Jul; 16(1):178-83. PubMed ID: 10933104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Equivalent bronchodilation with budesonide/formoterol combination via Easyhaler and Turbuhaler in patients with asthma.
    Lähelmä S; Vahteristo M; Metev H; Taseva M; Stamatova N; Bartha A; Schlezák J; Sairanen U
    Respir Med; 2016 Nov; 120():31-35. PubMed ID: 27817813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of two budesonide powder inhalers, Easyhaler and Turbuhaler, in steroid-naïve asthmatic patients.
    Schweisfurth H; Malinen A; Koskela T; Toivanen P; Ranki-Pesonen M;
    Respir Med; 2002 Aug; 96(8):599-606. PubMed ID: 12195841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of efficacy and safety of budesonide delivered via two dry powder inhalers.
    Kerwin EM; Pearlman DS; de Guia T; Carlsson LG; Gillen M; Uryniak T; Simonson SG
    Curr Med Res Opin; 2008 May; 24(5):1497-510. PubMed ID: 18419878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved lung delivery from a passive dry powder inhaler using an Engineered PulmoSphere powder.
    Duddu SP; Sisk SA; Walter YH; Tarara TE; Trimble KR; Clark AR; Eldon MA; Elton RC; Pickford M; Hirst PH; Newman SP; Weers JG
    Pharm Res; 2002 May; 19(5):689-95. PubMed ID: 12069174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioequivalence of budesonide plus formoterol (BF) Spiromax® and BF Turbohaler® (with and without charcoal block) in healthy volunteers.
    Weisfeld L; Shu Y; Shah TP
    Int J Clin Pharmacol Ther; 2015 Jul; 53(7):593-602. PubMed ID: 26042485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Pulmicort Turbuhaler Study Group.
    Nelson HS; Bernstein IL; Fink J; Edwards TB; Spector SL; Storms WW; Tashkin DP
    Chest; 1998 May; 113(5):1264-71. PubMed ID: 9596304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative systemic availability of budesonide in patients with asthma after inhalation from two dry powder inhalers.
    Persson G; Ankerst J; Gillen M; Bengtsson T; Thorsson L
    Curr Med Res Opin; 2008 May; 24(5):1511-7. PubMed ID: 18419877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects.
    Möllmann H; Wagner M; Krishnaswami S; Dimova H; Tang Y; Falcoz C; Daley-Yates PT; Krieg M; Stöckmann R; Barth J; Lawlor C; Möllmann AC; Derendorf H; Hochhaus G
    J Clin Pharmacol; 2001 Dec; 41(12):1329-38. PubMed ID: 11762560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic study for the establishment of bioequivalence of two inhalation treatments containing budesonide plus formoterol.
    Grekas N; Athanassiou K; Papataxiarchou K; Rizea Savu S; Silvestro L
    J Pharm Pharmacol; 2014 Dec; 66(12):1677-85. PubMed ID: 25109416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler.
    Selroos O; Halme M
    Thorax; 1991 Dec; 46(12):891-4. PubMed ID: 1792636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial.
    Dalby C; Polanowski T; Larsson T; Borgström L; Edsbäcker S; Harrison TW
    Respir Res; 2009 Oct; 10(1):104. PubMed ID: 19878590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Difference in resistance to humidity between commonly used dry powder inhalers: an in vitro study.
    Janson C; Lööf T; Telg G; Stratelis G; Nilsson F
    NPJ Prim Care Respir Med; 2016 Nov; 26():16053. PubMed ID: 27853177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler.
    Agertoft L; Pedersen S
    J Allergy Clin Immunol; 1997 Jun; 99(6 Pt 1):773-80. PubMed ID: 9215245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of Salbutamol Delivered from the Unit Dose Dry Powder Inhaler: Comparison with the Metered Dose Inhaler and Diskus Dry Powder Inhaler.
    Moore A; Riddell K; Joshi S; Chan R; Mehta R
    J Aerosol Med Pulm Drug Deliv; 2017 Jun; 30(3):164-172. PubMed ID: 28170282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
    Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacokinetics of inhaled budesonide.
    Donnelly R; Seale JP
    Clin Pharmacokinet; 2001; 40(6):427-40. PubMed ID: 11475468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.